Sign In
Buy ARVN
$7.70
-0.300 (-3.75%)
At Close: Jun 03, 2026
Does Arvinas (NASDAQ:ARVN) Have A Healthy Balance Sheet?
10:27am, Wednesday, 18'th Mar 2020
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Franklin Resources Inc. Takes $5.14 Million Position in Arvinas Inc (NASDAQ:ARVN)
10:20am, Wednesday, 18'th Mar 2020
Franklin Resources Inc. acquired a new stake in Arvinas Inc (NASDAQ:ARVN) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The inst
H.C. Wainwright Keeps Their Buy Rating on Arvinas Holding Company (ARVN)
11:20am, Tuesday, 17'th Mar 2020
In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Arvinas Holding Company (ARVN), with a price target of $50.00. The
H.C. Wainwright Keeps Their Buy Rating on Arvinas Holding Company (ARVN)
11:19am, Tuesday, 17'th Mar 2020
In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Arvinas Holding Company (ARVN –
Arvinas (NASDAQ:ARVN) Earns Buy Rating from Piper Sandler
07:40am, Tuesday, 17'th Mar 2020
Arvinas (NASDAQ:ARVN)‘s stock had its “buy” rating reissued by Piper Sandler in a report issued on Monday, TipRanks reports. They currently have a $58.00 price objective on the stock. Piper Sand
Arvinas Inc (NASDAQ:ARVN) Expected to Announce Quarterly Sales of $4.77 Million
06:44am, Tuesday, 17'th Mar 2020
Wall Street brokerages predict that Arvinas Inc (NASDAQ:ARVN) will post sales of $4.77 million for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Arvinas
Arvinas Reports Q4 and Full Year 2019 Financial Results
12:38pm, Monday, 16'th Mar 2020
Arvinas reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate update. The post Arvinas Reports Q4 and Full Year 2019 Financial Results appear
Arvinas, Inc. (ARVN) Reports Q4 Loss, Tops Revenue Estimates
12:15pm, Monday, 16'th Mar 2020
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -5.66% and 2.69%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Arvinas, Inc. (ARVN) Reports Q4 Loss, Tops Revenue Estimates
12:15pm, Monday, 16'th Mar 2020
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -5.66% and 2.69%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Arvinas Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
11:00am, Monday, 16'th Mar 2020
NEW HAVEN, Conn., March 16, 2020 -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation,.
Arvinas Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
11:00am, Monday, 16'th Mar 2020
NEW HAVEN, Conn., March 16, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...
Arvinas (NASDAQ:ARVN) Downgraded to Buy at BidaskClub
10:38am, Monday, 16'th Mar 2020
BidaskClub cut shares of Arvinas (NASDAQ:ARVN) from a strong-buy rating to a buy rating in a research note released on Friday, BidAskClub reports. Several other brokerages have also issued reports on
Zacks: Analysts Expect Arvinas Inc (NASDAQ:ARVN) Will Post Earnings of -$0.53 Per Share
09:30am, Sunday, 15'th Mar 2020
Equities analysts forecast that Arvinas Inc (NASDAQ:ARVN) will report earnings of ($0.53) per share for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Arvinas’ ea
Charles Schwab Investment Management Inc. Raises Stake in Arvinas Inc (NASDAQ:ARVN)
09:56am, Saturday, 14'th Mar 2020
Charles Schwab Investment Management Inc. raised its holdings in shares of Arvinas Inc (NASDAQ:ARVN) by 36.2% during the fourth quarter, according to its most recent disclosure with the Securities and
